Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2011, Article ID 163472, 6 pages
http://dx.doi.org/10.1155/2011/163472
Case Report

Recurrent PET FDG Uptake after Sequential Chemotherapy and Radiation Therapy for DLBCL of the Tibia: A Case Report and Review of the Literature

1Division of Radiation Oncology, Department of Radiology, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, USA
2Division of Orthopedics, Department of Surgery, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, USA
3Division of Nuclear Medicine, Department of Radiology, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, USA
4Division of Interventional Radiology, Department of Radiology, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, USA

Received 20 July 2011; Accepted 18 August 2011

Academic Editors: L. Beex, A. Kolacinska, O. Ozyilkan, and M. Ryberg

Copyright © 2011 Edward F. Miles et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Freeman, J. W. Berg, and S. J. Cutler, “Occurrence and prognosis of extranodal lymphomas,” Cancer, vol. 29, no. 1, pp. 252–260, 1972. View at Google Scholar · View at Scopus
  2. M. U. Jawad, M. M. Schneiderbauer, E. S. Min, M. C. Cheung, L. G. Koniaris, and S. P. Scully, “Primary lymphoma of bone in adult patients,” Cancer, vol. 116, no. 4, pp. 871–879, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. Beal, L. Allen, and J. Yahalom, “Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients,” Cancer, vol. 106, no. 12, pp. 2652–2656, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. P. Catlett, S. A. Williams, S. C. O'Connor, J. Krishnan, and V. Malkovska, “Primary lymphoma of bone: an institutional experience,” Leukemia and Lymphoma, vol. 49, no. 11, pp. 2125–2132, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. D. G. Power, G. P. McVey, G. Korpanty et al., “Primary bone lymphoma: single institution case series,” Irish Journal of Medical Science, vol. 177, no. 3, pp. 247–251, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. Trotti, AJCC Cancer Staging Handbook, American Joint Committee on Cancer, Chicago, Ill, USA, 7th edition, 2010.
  7. S. A. Rosenberg, “Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas,” Cancer Treatment Reports, vol. 61, no. 6, pp. 1023–1048, 1977. View at Google Scholar · View at Scopus
  8. M. A. Shipp, D. P. Harrington, J. R. Andersen et al., “A predictive model for aggressive non-Hodgkin's lymphoma,” New England Journal of Medicine, vol. 329, no. 14, pp. 987–994, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. D. Zelenetz, J. S. Abramson, R. H. Advani et al., “Non-Hodgkin's lymphomas clinical practice guidelines in oncology,” Journal of the National Comprehensive Cancer Network, vol. 8, no. 3, pp. 288–334, 2010. View at Google Scholar · View at Scopus
  10. M. Pfreundschuh, L. Trümper, A. Österborg et al., “CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group,” Lancet Oncology, vol. 7, no. 5, pp. 379–391, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. Pfreundschuh, J. Schubert, M. Ziepert et al., “Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60),” The Lancet Oncology, vol. 9, no. 2, pp. 105–116, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. P. Miller, “The limits of limited stage lymphoma,” Journal of Clinical Oncology, vol. 22, no. 15, pp. 2982–2984, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. R. K. Fairbanks, J. A. Bonner, C. Y. Inwards et al., “Treatment of stage IE primary lymphoma of bone,” International Journal of Radiation Oncology Biology Physics, vol. 28, no. 2, pp. 363–372, 1994. View at Google Scholar · View at Scopus
  14. D. T. Marshall, R. J. Amdur, M. T. Scarborough, N. P. Mendenhall, and W. W. Virkus, “Stage IE primary nonHodgkin's lymphoma of bone,” Clinical Orthopaedics and Related Research, no. 405, pp. 216–222, 2002. View at Google Scholar · View at Scopus
  15. D. R. Ford, D. Wilson, S. Sothi, R. Grimer, and D. Spooner, “Primary bone lymphoma—treatment and outcome,” Clinical Oncology, vol. 19, no. 1, pp. 50–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Ramadan, T. Shenkier, L. H. Sehn, R. D. Gascoyne, and J. M. Connors, “A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency,” Annals of Oncology, vol. 18, no. 1, pp. 129–135, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Dubey, C. S. Ha, P. C. Besa et al., “Localized primary malignant lymphoma of bone,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 5, pp. 1087–1093, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Christie, K. Dear, T. Le et al., “Limited chemotherapy and shrinking field radiotherapy for osteolymphoma (primary bone lymphoma): results from the Trans-Tasman radiation oncology group 99.04 and Australasian Leukaemia and lymphoma group LY02 prospective trial,” International Journal of Radiation Oncology Biology Physics, vol. 80, no. 4, pp. 1164–1170, 2011. View at Publisher · View at Google Scholar · View at PubMed
  19. J. Baar, R. L. Burkes, R. Bell, M. E. Blackstein, B. Fernandes, and F. Langer, “Primary non-Hodgkin's lymphoma of bone: a clinicopathologic study,” Cancer, vol. 73, no. 4, pp. 1194–1199, 1994. View at Google Scholar · View at Scopus
  20. L. Cai, M. C. Stauder, Y. J. Zhang et al., “Early stage primary bone lymphoma: a retrospective, multicenter rare cancer network study,” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 3, supplement, p. S84, 2010. View at Publisher · View at Google Scholar
  21. J. A. Lee, S. J. Huh, D. Oh, and D. S. Bae, “Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion,” Annals of Nuclear Medicine, vol. 22, no. 2, pp. 139–141, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. H. Sohn, H. J. Jeong, S. T. Lim, S. H. Song, and C. Y. Yim, “F-18 FDG uptake in osteonecrosis mimicking bone metastasis on PET/CT images,” Clinical Nuclear Medicine, vol. 32, no. 6, pp. 496–497, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus